The growth can primarily be attributed to factors such as the large number of approvals for contrast agents in different geographies and increasing number of public and private diagnostic centers. On the other hand, the side effects and allergic reactions associated with contrast agents are expected to limit the market growth to a certain extent.
The global contrast injectors market is segmented on the basis of application, product, and region. Based on application, the contrast injectors market is segmented into radiology, interventional cardiology, and interventional radiology. The interventional cardiology segment is projected to grow at the highest CAGR during the forecast period. However, the radiology segment is expected to command the largest share of the contrast injector market in 2016.
Based on product, the market is categorized into injector systems, consumables, and accessories. The injector systems category is further segmented into CT injector systems, MRI injector systems, and angiography injector systems. The CT injector systems segment is expected to command the largest share of the market in 2016. The MRI injector systems segment is projected to grow at the highest CAGR during the forecast period. The consumables segment is expected to account for the largest share of the market in 2016.
The growth of the consumables segment can largely be attributed to the recurring use in every procedure conducted. The consumables segment is further segmented into injector heads, syringes, tubing, and other consumables (scan bags, valves, vials, and spikes). The injector heads segment is estimated to account for the largest share of the consumables market in 2016. The injector heads segment is further divided into single head injectors, dual head injectors, and syringeless injectors. The single head injectors segment is expected to command the largest share of the market in 2016. The syringeless injectors segment is projected to grow at the highest CAGR during the forecast period.
Based on region, North America is expected to account for the largest share of the global contrast injector market. North America’s leadership position in the market can be attributed to the increase in the number of diagnostics imaging centers and tests, rising prevalence of chronic diseases, increasing aging population in the U.S., increasing number of cardiac arrests, and rising incidence of diseases.
In the coming years, the contrast injector market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in the region can be attributed to the rising approvals for various contrast agents in Asia-Pacific countries, developing markets, and the growing presence of international players in this region. In addition, the availability of government support for research, high healthcare expenditure in APAC countries, increase in aging population, and increasing cancer incidences are expected to support the growth of the Asia-Pacific contrast injector market.
Key players in the global contrast injectors market include Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France), Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo RT Co., Ltd. (China).
Know more about Contrast Injectors Market - https://www.marketsandmarkets.com/PressReleases/contrast-injector.asp
